Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma.
Ninety-three patients received ruby laser panretinal photocoagulation in one eye for diabetic retinopathy and we examined them at an average time of 7.1 years later. In 14 patients, the untreated eye developed rubeosis iridis and the contralateral treated eye did not. In seven patients, the untreated eye developed angle neovascularization and the contralateral eye did not. The untreated eye developed neovascular glaucoma and the contralateral treated eye did not in four patients. Our findings suggest that eyes with proliferative retinopathy that received panretinal photocoagulation are less likely to develop rubeosis iridis, angle neovascularization, and probably neovascular glaucoma, than those eyes not receiving panretinal photocoagulation.
D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000473:pathology / Q000601:surgery*; D005260:Female; D005901:Glaucoma / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007500:Iritis / Q000473:pathology / Q000601:surgery*; D008028:Light Coagulation; D008297:Male; D008875:Middle Aged